Back to results
US 2023/0405054 A1Published application
Novel nr1 es-derived neural stem cells having a normal karyotype and uses thereof
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorGary K. Steinberg
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided relating to NR1 ES-derived neural stem cells. The cells are useful in methods of treatment for an adverse neurologic conditions, including without limitation stoke.
Claims21
A method for treating a subject suffering a stroke or traumatic brain injury by increasing exogenous trophic factors in the cerebral cortex to augment endogenous neural repair processes in the subject, the method comprising:
- administering to the subject a therapeutically effective amount of non-genetically modified NR1 ES-derived neural stem cells having a normal karyotype, which cells express trophic factors, so as to restore neurologic function in the subject, thereby treating the subject suffering a stroke or traumatic brain injury.
21-41. (canceled)
Dependencies are inferred from the claim text.